A patent currently prohibits any generic Exubera from being manufactured. Although some companies claim to sell it, these medications are fake, substandard, and potentially dangerous. The earliest date that generic Exubera could become available is in 2010, when the patent expires. However, other circumstances could extend the exclusivity period beyond this time, such as other patents for specific uses of Exubera or lawsuits.
In October 2007, Pfizer announced it will stop making Exubera. This decision was voluntary and was not based on any safety concern; Pfizer states that Exubera has not met its expectations in terms of sales. Starting in October 2007, Exubera will be available for an additional three months, which will give people enough time to change from Exubera to another type of insulin or other diabetes medication.
An Introduction to Generic ExuberaExubera® (inhaled insulin) is a prescription medication that has been licensed to treat both type 1 and type 2 diabetes.
The drug is manufactured by Pfizer and is currently under the protection of a patent, which prevents any generic Exubera from being manufactured in the United States. Yet, if you search the Internet for "generic Exubera," you may find a number of companies selling it. The fact is that these medicines are fake, substandard, and potentially dangerous. There may be generic Exubera available from another country, but there is really no way of knowing if you are getting genuine Exubera or not. Therefore, you should not buy any generic Exubera until there is an approved version available.
When Will Generic Exubera Be Available?The earliest date that a generic version of Exubera could become available is in 2010. However, other circumstances could come up to extend the exclusivity period beyond this time, such as other patents for specific Exubera uses or lawsuits. Once the patent expires, several companies will likely begin manufacturing generic Exubera.